Cohen A M
Drug Metab Dispos. 1975 Jul-Aug;3(4):303-8.
The excretion, distribution, and metabolism of ftorafur was studied in rats following a single intravenous injection of radioactively labeled drug. Approximately 55% of the administered radioactivity was excreted as 14CO2, while 23% was eliminated via the urinary route in 24 hr. Less than 2% was excreted in the feces. The major excretory product found in the urine was unmetabolized ftorafur. However, the proportions of radioactively labeled metabolites such as 5-fluorouracil and urea increased with time after injection. The half-life of ftorafur in plasma was estimated to be approximately 5 hr. The drug was fairly evenly distributed to liver, small intestine, spleen, kidney, and brain. Highest initial concentrations were found in the liver, which also retained more drug for a longer period than the other tissues. The liver was also found to contain the highest initial proportions of 5-fluorouracil and its metabolites. The results obtained are consistent with the suggestion that ftorafur may be a depot form of 5-fluorouracil and that the liver may be the primary site at which the latter drug is released in vivo.
在大鼠单次静脉注射放射性标记药物后,对替加氟的排泄、分布和代谢进行了研究。给药放射性的约55%以14CO2形式排泄,而23%在24小时内通过尿液途径消除。粪便排泄量不到2%。尿液中发现的主要排泄产物是未代谢的替加氟。然而,注射后随着时间的推移,放射性标记代谢物如5-氟尿嘧啶和尿素的比例增加。替加氟在血浆中的半衰期估计约为5小时。该药物在肝脏、小肠、脾脏、肾脏和大脑中分布相当均匀。最初在肝脏中发现最高浓度,肝脏比其他组织保留更多药物的时间也更长。还发现肝脏中5-氟尿嘧啶及其代谢物的初始比例最高。所得结果与以下观点一致,即替加氟可能是5-氟尿嘧啶的储存形式,并且肝脏可能是体内释放后一种药物的主要部位。